the market will value AT1 on its expected growth, which won’t really make many take notice until the ramp up in production is fully in place , which is expected to be mid to end of 2021.
What may accelerate this and back the supply with customer orders is the FDA approval, which will mean at least 2m units will be sold to Access Bio by Sep 2021... and that is only the beginning...
but before it becomes reality/market prices it in... we need that FDA EUA early 2021.
AT1 Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
